News/ News/ Oncology FDA clears Lilly’s Retevmo for RET-positive lung, thyroid cancers Phil Taylor Blueprint Medicines, Eli Lilly, novel targeted cancer treatments, Oncology, Retmevo, selpercatinib 0 Comment Eli Lilly now has a second approved drug from its takeover of Loxo Oncology last year after getting Share X FDA clears Lilly’s Retevmo for RET-positive lung, thyroid cancers https://pharmaphorum.com/news/fda-clears-lillys-retevmo-for-ret-positive-lung-thyroid-cancers/